Loading
IG
Interleukin Genetics Inc Stock: price and insider trades · United States
No insider purchase over the last 90 days. The latest, by PYXIS INNOVATIONS INC, was filed 03 Aug 2016.
Interleukin Genetics Inc: what insiders have been doing
This page follows insider dealings at Interleukin Genetics Inc as filed with SEC (Form 4). Nothing new has been filed by managers of Interleukin Genetics Inc in twelve months, the latest record being from 3 August 2016.
The full history, which starts in 2016, counts 8 purchases against no sales.
Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Insider Decl.
19
Thresholds
n/a
Buy Volume
€5M
8 ops. · all time
Sell Volume
n/a
n/a
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Last declaration on 3 August 2016
Declarations19 total
5,030,181 shares@ US$0.0994100.0% of flowCommon StockSEC:0000950138-16-001236:0
Canonical exit: 27 Oct 2016 (T+90)
20,120,724 shares@ US$0.0994100.0% of flowCommon StockSEC:0001209191-16-134920:0
Canonical exit: 27 Oct 2016 (T+90)
29,616,700 shares@ US$0.099498.1% of flowCommon StockSEC:0000899243-16-026077:0
Canonical exit: 27 Oct 2016 (T+90)
564,386 shares@ US$0.09941.9% of flowCommon StockSEC:0000899243-16-026077:1
Canonical exit: 27 Oct 2016 (T+90)
20,120,724 shares@ US$0.0994100.0% of flowCommon StockSEC:0001209191-16-134937:0
Canonical exit: 27 Oct 2016 (T+90)
20,120,724 shares@ US$0.0994100.0% of flowCommon StockSEC:0001209191-16-134927:0
Canonical exit: 27 Oct 2016 (T+90)
20,120,724 shares@ US$0.0994100.0% of flowCommon StockSEC:0001209191-16-134938:0
Canonical exit: 27 Oct 2016 (T+90)
20,120,724 shares@ US$0.0994100.0% of flowCommon StockSEC:0001209191-16-134934:0
Canonical exit: 27 Oct 2016 (T+90)
20,120,724 shares@ US$0.0994100.0% of flowCommon StockSEC:0001209191-16-134931:0
Canonical exit: 27 Oct 2016 (T+90)
20,120,724 shares@ US$0.0994100.0% of flowCommon StockSEC:0001209191-16-134921:0
Canonical exit: 27 Oct 2016 (T+90)
20,120,724 shares@ US$0.0994100.0% of flowCommon StockSEC:0001209191-16-134929:0
Canonical exit: 27 Oct 2016 (T+90)
20,120,724 shares@ US$0.0994100.0% of flowCommon StockSEC:0001209191-16-134925:0
Canonical exit: 27 Oct 2016 (T+90)
▲
Same trade as the filing by M. James Barrett, counted once
2M USD31SEC
20,120,724 shares@ US$0.0994100.0% of flowCommon StockSEC:0001209191-16-134919:0
Canonical exit: 27 Oct 2016 (T+90)
20,120,724 shares@ US$0.0994100.0% of flowCommon StockSEC:0001209191-16-134935:0
Canonical exit: 27 Oct 2016 (T+90)
20,120,724 shares@ US$0.0994100.0% of flowCommon StockSEC:0001209191-16-134932:0
Canonical exit: 27 Oct 2016 (T+90)
100,603 shares@ US$0.0994100.0% of flowCommon StockSEC:0001144204-16-115762:0
Canonical exit: 27 Oct 2016 (T+90)
100,603 shares@ US$0.0994100.0% of flowCommon StockSEC:0001144204-16-115764:0
Canonical exit: 27 Oct 2016 (T+90)
25,150 shares@ US$0.0994100.0% of flowCommon StockSEC:0001144204-16-115763:0
Canonical exit: 27 Oct 2016 (T+90)
100,603 shares@ US$0.0994100.0% of flowCommon StockSEC:0001144204-16-115761:0
Canonical exit: 27 Oct 2016 (T+90)
19 of 19 declarations
About Interleukin Genetics Inc
Interleukin Genetics Inc is a company focused on developing genetic tests for health and wellness. It specializes in identifying genetic predispositions to diseases and responses to treatments.
